In other cancers and cell model systems, YAP and TAZ drive EMT,26, 27, 28 migration/metastasis,29, 30 and chemoresistance,31, 32 while their expression and activation are associated with poor clinical outcomes across a range of cancer types.33, 34, 35, 36. The gene discussed is YAP1; the disease is cancer.